Gastrointestinal Adverse Events Gastrointestinal (GI) adverse events are the hallmark safety finding with all GLP-1 receptor agonists, reflecting the physiological effects of GLP-1 signaling on gastric motility, gastric emptying, and central appetite regulation
From venom to drug Once the hormone was identified and understood, it was just a matter of time before researchers turned the biological pathway into an actionable drug approach
Aetna GLP-1 Coverage: What You Need to Know If you have Aetna insurance and you are considering a GLP-1 medication like Wegovy or Zepbound for weight loss, the first thing to understand is that coverage varies significantly by plan type
pharmaceutical landscape, GLP-1 medications have surged to blockbuster status, driven by soaring demand for both diabetes management and weight loss solutions
If symptoms persist despite these measures, your healthcare provider may consider adjusting your medication dose or slowing the titration schedule to improve tolerability